KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Revenue: 2017-2024

Historic Revenue for Adaptive Biotechnologies (ADPT) over the last 8 years, with Dec 2024 value amounting to $179.0 million.

  • Adaptive Biotechnologies' Revenue rose 102.38% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $252.8 million, marking a year-over-year increase of 42.57%. This contributed to the annual value of $179.0 million for FY2024, which is 5.10% up from last year.
  • As of FY2024, Adaptive Biotechnologies' Revenue stood at $179.0 million, which was up 5.10% from $170.3 million recorded in FY2023.
  • Adaptive Biotechnologies' 5-year Revenue high stood at $185.3 million for FY2022, and its period low was $98.4 million during FY2020.
  • In the last 3 years, Adaptive Biotechnologies' Revenue had a median value of $179.0 million in 2024 and averaged $178.2 million.
  • In the last 5 years, Adaptive Biotechnologies' Revenue spiked by 56.88% in 2021 and then fell by 8.11% in 2023.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Revenue stood at $98.4 million in 2020, then skyrocketed by 56.88% to $154.3 million in 2021, then grew by 20.06% to $185.3 million in 2022, then fell by 8.11% to $170.3 million in 2023, then rose by 5.10% to $179.0 million in 2024.